Cited by 204Adipokines, Inflammation, and Metabolic DiseasesAcute Myeloid Leukemia ResearchMetabolism, Diabetes, and Cancer

TET2-loss-of-function-driven clonal hematopoiesis exacerbates experimental insulin resistance in aging and obesity

Open access
Fuster, José J., Zuriaga, María A., Zorita, Virginia, MacLauchlan, Susan, Polackal, Maya N., Viana-Huete, Vanesa, Ferrer-Pérez, Alba, Matesanz, Nuria +5 more·2020·Cell Reports

Abstract

Human aging is frequently accompanied by the acquisition of somatic mutations in the hematopoietic system that induce clonal hematopoiesis, leading to the development of a mutant clone of hematopoietic progenitors and leukocytes. This somatic-mutation-driven clonal hematopoiesis has been associated with an increased incidence of cardiovascular disease and type 2 diabetes, but whether this epidemiological association reflects a direct, causal contribution of mutant hematopoietic and immune cells to age-related metabolic abnormalities remains unexplored. Here, we show that inactivating mutations in the epigenetic regulator TET2, which lead to clonal hematopoiesis, aggravate age- and obesity-related insulin resistance in mice. This metabolic dysfunction is paralleled by increased expression of the pro-inflammatory cytokine IL-1β in white adipose tissue, and it is suppressed by pharmacological inhibition of NLRP3 inflammasome-mediated IL-1β production. These findings support a causal contribution of somatic TET2 mutations to insulin resistance and type 2 diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2020.108326

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Alternatives via adoptive transfer of unfractionated BM cells into nonirradiated mice are limited by a fixed availability of BM niche space and restricted starting clonal fractions.

    “Although alternatives have been established via adoptive transfer of unfractionated BM cells into nonirradiated mice, these models are limited by a fixed availability of BM niche space and, thus, restricted starting clonal fractions.40,41”

    From Aging drives <i>Tet2</i> <i>+/−</i> clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [41]

    STAR★METHODS, Method Details (page unavailable), describes transfer of unfractionated bone marrow cells into nonirradiated mice. The Results on age-related insulin resistance (page unavailable) report a small initial donor-cell fraction, but neither passage attributes that fraction to fixed bone-marrow niche space or states that niche space restricts starting clonal fractions. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 40 · Cited by 204

Research works printed but not linked: 32

  1. Abplanalp WT, Mas-Peiro S, Cremer S, John D, Dimmeler S, and Zeiher AM (2020). Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure. JAMA Cardiol. Published online July 8, 2020. In press. 10.1001/jamacardio.2020.2468. PMC7344831 32639511 · DOI
  2. Bick AG, Weinstock JS, Nandakumar SK, Fulco CP, Leventhal MJ, Bao EL, Nasser J, Zekavat SM, Szeto MD, Laurie C, (2019). Inherited Causes of Clonal Hematopoiesis of Indeterminate Potential in TOPMed Whole Genomes. bioRxiv. 10.1101/782748. · DOI
  3. Bonnefond A, Skrobek B, Lobbens S, Eury E, Thuillier D, Cauchi S, Lantieri O, Balkau B, Riboli E, Marre M, (2013). Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications. Nat. Genet 45, 1040– 1043. 23852171
  4. Buscarlet M, Provost S, Zada YF, Bourgoin V, Mollica L, Dubé MP, and Busque L (2018). Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A. Blood 132, 277– 280. 29764839
  5. Busch K, and Rodewald HR (2016). Unperturbed vs. post-transplantation hematopoiesis: both in vivo but different. Curr. Opin. Hematol 23, 295– 303. 27213498 PMC4900429
  6. Cavelti-Weder C, Babians-Brunner A, Keller C, Stahel MA, Kurz-Levin M, Zayed H, Solinger AM, Mandrup-Poulsen T, Dinarello CA, and Donath MY (2012). Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care 35, 1654– 1662. 22699287 PMC3402269
  7. Claycombe KJ, Wu D, Nikolova-Karakashian M, Palmer H, Beharka A, Paulson KE, and Meydani SN (2002). Ceramide mediates age-associated increase in macrophage cyclooxygenase-2 expression. J. Biol. Chem 277, 30784– 30791. 12072440
  8. Donath MY, Meier DT, and Böni-Schnetzler M (2019). Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease. Endocr. Rev 40, 1080– 1091. 31127805 PMC6624792
  9. Everett BM, Donath MY, Pradhan AD, Thuren T, Pais P, Nicolau JC, Glynn RJ, Libby P, and Ridker PM (2018). Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes. J. Am. Coll. Cardiol 71, 2392– 2401. 29544870
  10. Fuster JJ, and Walsh K (2018). Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease. Circ. Res 122, 523– 532. 29420212 PMC5826570
  11. Fuster JJ, Zuriaga MA, Ngo DT, Farb MG, Aprahamian T, Yamaguchi TP, Gokce N, and Walsh K (2015). Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion. Diabetes 64, 1235– 1248. 25352637 PMC4375084
  12. Fuster JJ, Ouchi N, Gokce N, and Walsh K (2016). Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Circ. Res 118, 1786– 1807. 27230642 PMC4887147
  13. Fuster JJ, MacLauchlan S, Zuriaga MA, Polackal MN, Ostriker AC, Chakraborty R, Wu CL, Sano S, Muralidharan S, Rius C, (2017). Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 355, 842– 847. 28104796 PMC5542057
  14. Gao D, Madi M, Ding C, Fok M, Steele T, Ford C, Hunter L, and Bing C (2014). Interleukin-1b mediates macrophage-induced impairment of insulin signaling in human primary adipocytes. Am. J. Physiol. Endocrinol. Metab 307, E289– E304. 24918199 PMC4121578
  15. Genovese G, Kähler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, Chambert K, Mick E, Neale BM, Fromer M, (2014). Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med 371, 2477– 2487. 25426838 PMC4290021
  16. Jager J, Grémeaux T, Cormont M, Le Marchand-Brustel Y, and Tanti JF (2007). Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148, 241– 251. 17038556 PMC1971114
  17. Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, McConkey M, Gupta N, Gabriel S, Ardissino D, (2017). Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. N. Engl. J. Med 377, 111– 121. 28636844 PMC6717509
  18. Kataria Y, Ellervik C, and Mandrup-Poulsen T (2019). Treatment of type 2 diabetes by targeting interleukin-1: a meta-analysis of 2921 patients. Semin. Immunopathol 41, 413– 425. 31025084
  19. Ko M, Bandukwala HS, An J, Lamperti ED, Thompson EC, Hastie R, Tsangaratou A, Rajewsky K, Koralov SB, and Rao A (2011). Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc. Natl. Acad. Sci. USA 108, 14566– 14571. 21873190 PMC3167529
  20. Lightle SA, Oakley JI, and Nikolova-Karakashian MN (2000). Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging. Mech. Ageing Dev 120, 111– 125. 11087909
  21. Lu R, Czechowicz A, Seita J, Jiang D, and Weissman IL (2019). Clonal-level lineage commitment pathways of hematopoietic stem cells in vivo. Proc. Natl. Acad. Sci. USA 116, 1447– 1456. 30622181 PMC6347684
  22. Ohanian J, Liao A, Forman SP, and Ohanian V (2014). Age-related remodeling of small arteries is accompanied by increased sphingomyelinase activity and accumulation of long-chain ceramides. Physiol. Rep 2, e12015. 24872355 PMC4098743
  23. Peiró C, Lorenzo Ó, Carraro R, and Sánchez-Ferrer CF (2017). IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus. Front. Pharmacol 8, 363. 28659798 PMC5468794
  24. Sano S, Oshima K, Wang Y, MacLauchlan S, Katanasaka Y, Sano M, Zuriaga MA, Yoshiyama M, Goukassian D, Cooper MA, (2018). Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome. J. Am. Coll. Cardiol 71, 875– 886. 29471939 PMC5828038
  25. Shimoto M, Sugiyama T, and Nagasawa T (2017). Numerous niches for hematopoietic stem cells remain empty during homeostasis. Blood 129, 2124– 2131. 28130213
  26. Sloan-Lancaster J, Abu-Raddad E, Polzer J, Miller JW, Scherer JC, De Gaetano A, Berg JK, and Landschulz WH (2013). Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetes. Diabetes Care 36, 2239– 2246. 23514733 PMC3714510
  27. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, and Dixit VD (2011). The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med 17, 179– 188. 21217695 PMC3076025
  28. Wang Y, Sano S, Yura Y, Ke Z, Sano M, Oshima K, Ogawa H, Horitani K, Min KD, Miura-Yura E, (2020). Tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction. JCI Insight 5, e135204. PMC7213793 32154790
  29. Wu D, Ren Z, Pae M, Guo W, Cui X, Merrill AH, and Meydani SN (2007). Aging up-regulates expression of inflammatory mediators in mouse adipose tissue. J. Immunol 179, 4829– 4839. 17878382
  30. Xie M, Lu C, Wang J, McLellan MD, Johnson KJ, Wendl MC, McMichael JF, Schmidt HK, Yellapantula V, Miller CA, (2014). Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med 20, 1472– 1478. 25326804 PMC4313872
  31. Youm YH, Kanneganti TD, Vandanmagsar B, Zhu X, Ravussin A, Adijiang A, Owen JS, Thomas MJ, Francis J, Parks JS, and Dixit VD (2012). The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence. Cell Rep. 1, 56– 68. 22832107 PMC3883512
  32. Zink F, Stacey SN, Norddahl GL, Frigge ML, Magnusson OT, Jonsdottir I, Thorgeirsson TE, Sigurdsson A, Gudjonsson SA, Gudmundsson J, (2017). Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood 130, 742– 752. 28483762 PMC5553576

Authors
Fuster, J. J., Zuriaga, M. A., Zorita, V., MacLauchlan, S., Polackal, M. N., Viana-Huete, V., Ferrer-Pérez, A., Matesanz, N., Herrero-Cervera, A., Sano, S., Cooper, M. A., González-Navarro, H., & Walsh, K.
Affiliations
  • Boston University (US)
  • Spanish National Centre for Cardiovascular Research (ES)
  • INCLIVA Health Research Institute (ES)
  • The University of Queensland (AU)
Corresponding author
  • Fuster, José J.
  • Walsh, Kenneth
Venue
Cell Reports
Publisher
Elsevier BV
Published
2020-10
Volume
33
Issue
4
Pages
108326
ISSN
2211-1247 (ISSN-L)
OpenAlex
W3094666465
Cited by
204
References
40
Citations by year
2026: 33 · 2025: 34 · 2024: 28 · 2023: 41 · 2022: 44 · 2021: 24
FWCI
19.54
Type
journal article
Language
en
Open access
Locations
  • Cell Reports (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion, other-oa)
  • PubMed Central (acceptedVersion, cc-by-nc-nd)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-nd)
Funders
  • National Institutes of Health
  • Ministerio de Ciencia e Innovación
  • “la Caixa” Foundation
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
clonal hematopoiesis, TET2, loss-of-function mutations, somatic mutations, aging, obesity, insulin resistance, type 2 diabetes, IL-1β, NLRP3 inflammasome, white adipose tissue inflammation, hematopoietic progenitor cells, epigenetic regulation
MeSH terms
Clonal Hematopoiesis, Aging, Animals, DNA-Binding Proteins, Humans, Insulin Resistance, Obesity, Dioxygenases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review